Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective 01. September 2021
Solactive China Healthcare Disruption Index:
In the ordinary rebalancing effective open September 01, 2021 the following index composition was implemented:
3SBIO INC | 0.8817 % |
AKESO INC | 1.3103 % |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 6.8662 % |
ALPHAMAB ONCOLOGY | 0.7466 % |
ANGELALIGN TECHNOLOGY INC | 2.592 % |
BEIGENE LTD | 8.8656 % |
BRII BIOSCIENCES LTD | 1.0368 % |
CANSINO BIOLOGICS INC | 5.1266 % |
CARSGEN THERAPEUTICS HOLDING | 0.8996 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 1.5021 % |
EVEREST MEDICINES LTD | 0.5701 % |
GENSCRIPT BIOTECH CORP | 3.0912 % |
HANSOH PHARMACEUTICAL GROUP CO | 5.0203 % |
INNOCARE PHARMA LTD | 1.3012 % |
INNOVENT BIOLOGICS INC | 3.6481 % |
JD HEALTH INTERNATIONAL INC | 8.1423 % |
JOINN LABORATORIES CHINA C-H | 2.3447 % |
KEYMED BIOSCIENCES INC | 0.5686 % |
KINTOR PHARMACEUTICAL LTD | 1.206 % |
LIFETECH SCIENTIFIC CORP | 0.7756 % |
MICROPORT CARDIOFLOW MEDTECH | 0.7668 % |
MICROPORT SCIENTIFIC CORP | 3.4947 % |
NEW HORIZON HEALTH LTD | 0.8163 % |
PEIJIA MEDICAL LTD | 0.6077 % |
PING AN HEALTHCARE AND TECHNOL | 2.627 % |
REMEGEN CO LTD-H | 1.9638 % |
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 2.3092 % |
SHANGHAI JUNSHI BIOSCIENCES CO LTD | 2.2154 % |
SIMCERE PHARMACEUTICAL GROUP | 0.8151 % |
SINO BIOPHARMACEUTICAL LTD ORD | 4.8951 % |
VENUS MEDTECH HANGZHOU INC | 0.662 % |
WUXI APPTEC CO LTD | 8.4707 % |
WUXI BIOLOGICS CAYMAN INC | 8.4432 % |
YIDU TECH INC | 1.2627 % |
ZAI LAB LTD | 4.1548 % |